Developer docs
API playgroundTry for free, no card

Search company profiles

SamaCare

Full company profile

uuid0000goa

Namestring
SamaCare
Legal namestring
SamaCare Inc.
Websiteurl
samacare.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

SamaCare operates an AI-native medical benefit prior authorization platform that connects U.S. specialty healthcare providers with pharmaceutical manufacturers through a single unified workflow. Built on a proprietary dataset of over 2 million prior authorizations captured across 30,000+ specialty practices, 97% of U.S. payers, and 8+ years of continuous operation, the platform automates submission, tracking, and denial prevention for high-cost specialty medications administered in retina, oncology, neurology, rheumatology, and infusion settings. Core technology components include a real-time prior authorization data engine, AI-powered point-of-care support, Policy Pre-Check, bulk automated submission, and human-in-the-loop AI processes that learn from frontline specialists. The November 2025 launch of SamaCare Plus extends the platform into touchless, AI-driven prior authorization with provider oversight.

The business model is a two-sided freemium: specialty practices use the core platform free of charge, generating the data asset that underpins SamaCare's value proposition. Revenue is generated on the life sciences side from pharmaceutical manufacturers who subscribe to premium data analytics (SamaCare Insights, Medical Benefit Prior Authorization Benchmarks), intervention services (PA Boost, Auth Inform), and strategic clinical justification support. Distribution combines direct enterprise sales with channel partnerships through Cencora, McKesson, Neuronet GPO, the American Rheumatology Network, NICA, and an EHR integration with NextGen Healthcare. Customers include 40% of leading pharmaceutical companies, with documented outcomes including up to 84% faster time to resolution, 29% higher approval rates, 24% lower patient churn, and up to 42% reduction in avoidable administrative denials. The company is privately held, venture-backed by Questa Capital, Vive Collective, and South Park Commons, and is led by founder and CEO Syam Palakurthy.

Short descriptiontext

SamaCare operates an AI-native medical benefit prior authorization platform serving U.S. specialty practices and pharmaceutical manufacturers, processing $6.2B+ in specialty drug spend annually across 30,000+ providers. The platform is free to providers; revenue comes from pharma clients paying for market access analytics, intervention services, and industry benchmarks.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical prior authorization, specialty drug access, healthcare workflow automation, market access analytics, AI prior authorization
Industry2 codes
PRIMARYHLACANAO
DTx/SaMD Deployment, Integration & Reimbursement Enablement
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code1 code
  • Custom Computer Programming Services541511
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Medical Benefit Prior Authorization Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Life Sciences / Pharmaceutical Services
TypeSubscription Recurring
Description

Premium services and data analytics for pharmaceutical brands to improve access to therapy. Revenue generated from pharmaceutical manufacturers who pay for market access insights, intervention support, and data analytics services. Clients include 40% of leading pharmaceutical companies.

samacare.com
2Provider Platform (Free Tier)
TypeFreemium
Description

SamaCare's prior authorization platform is free to clinics, ensuring patients get on the right therapy at the right time. This creates network effects and data advantages that benefit the pharmaceutical side of the business.

samacare.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Free prior authorization platform for providers
ModelFreemiumBilling cadenceMonthly
Notes

The core prior authorization platform is provided free of charge to specialty practices including retina, oncology, neurology, and rheumatology clinics.

samacare.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 7 records shown
1SamaCare Insights
Description

AI-powered data analytics and insights platform providing real-time prior authorization performance data and benchmarks.

samacare.com
+6 more records
Core offering1 text field

SamaCare operates an AI-native medical benefit prior authorization platform, known as the Script-to-Therapy Operating System, that automates submission, tracking, and denial prevention for specialty medications across all major U.S. payers. The platform is offered free to specialty healthcare providers and monetizes via premium data analytics and intervention services sold to pharmaceutical manufacturers, processing over $6.2B in annual specialty drug spend.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Up to 84% faster Time to Resolution
+6 more records
Product overview1 text field

SamaCare offers a unified Script-to-Therapy Operating System for medical benefit prior authorization, built on a best-in-class AI tech stack and the largest real-world dataset in medical benefit prior authorization. The core platform provides automated, AI-native prior authorization submission and tracking across all major U.S. payers, available free to specialty practices. The product portfolio includes multiple AI-powered modules: SamaCare Plus (touchless prior authorizations), Policy Pre-Check (policy alignment before submission), AI-Powered Point-of-Care Support (real-time denial avoidance guidance), and SamaCare Insights (data analytics for manufacturers). For life sciences clients, SamaCare offers premium services including PA Boost, Auth Inform, and strategic intervention services, along with the Medical Benefit Prior Authorization Benchmarks for industry-wide visibility. The platform processes over $6B+ in medical benefit drug spend annually across more than 15,000 providers and supports 40% of the U.S. ambulatory infusion center market.

Product and service7 records
1Script-to-Therapy Operating System (Provider Portal)
CategoryPrior Authorization Platform
2SamaCare Plus
CategoryPrior Authorization Platform
3SamaCare Insights
CategoryMarket Access Analytics
4PA Boost
CategoryLife Sciences Premium Service
5Auth Inform
CategoryLife Sciences Premium Service
6Medical Benefit Prior Authorization Benchmarks
CategoryMarket Access Analytics
7Premium Services (Strategic Interventions)
CategoryLife Sciences Premium Service
Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-01-25
Description

National partnership to bring streamlined prior authorization to a network of over 460 community-based rheumatology providers.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-01-10
Description

Integration partnership enabling seamless data transfer between NextGen EHR and SamaCare's prior authorization platform.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Co-hosted webinar on unifying prior authorization data for infusion centers; ongoing collaboration on industry standards and education.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Co-presented webinar on infusion operations and workflow automation with leading infusion provider FlexCare.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Content partnership for article publication on provider-administered drug launches in competitive markets.

6Immunoglobulin National Society (IgNS)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Featured partner on Road to Care podcast episode about IG therapy standardization; both organizations focused on improving patient access to specialty therapies.

samacare.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1CoverMyMeds
TypeDirect peer
Description

The leading electronic prior authorization (ePA) platform for prescriptions and specialty medications, now part of McKesson's RxTS business. Directly comparable to SamaCare in automating PA workflows between providers, payers, and pharma manufacturers.

TypeDirect peer
Description

Operates one of the largest ePA networks in the U.S., connecting providers, payers, and pharmacy benefit managers. Comparable to SamaCare as a network-driven prior authorization and medication intelligence infrastructure player.

TypeDirect peer
Description

AI-driven prior authorization and utilization management platform focused on specialty care and value-based care arrangements. Direct competitor to SamaCare in automating medical and specialty PA with intelligent clinical decisioning.

TypeEmerging player
Description

AI-native prior authorization company applying large language models to reduce administrative denials. Comparable to SamaCare Plus in targeting touchless PA with deep AI capabilities, though at an earlier stage.

TypeBroad incumbent
Description

Public healthcare revenue cycle management platform with prior authorization capabilities as part of a broader RCM suite. Overlaps with SamaCare in PA workflows but serves a much wider hospital and ambulatory RCM footprint.

TypeBroad incumbent
Description

Largest healthcare technology and services platform in the U.S., including Change Healthcare, which provides PA, claims, and clinical connectivity solutions. Competes with SamaCare through vertically integrated payer-provider data and analytics.

TypeBroad incumbent
Description

Healthcare data, identity, and automation vendor with prior authorization and eligibility solutions. Comparable to SamaCare in automating medical benefit workflows for providers and payers, but as part of a broader credit and data analytics portfolio.

TypeEmerging player
Description

Intelligent automation platform using AI to streamline administrative workflows for healthcare providers, including prior authorization. Comparable to SamaCare in targeting PA automation and broader workflow reduction with AI.

TypeEmerging player
Description

Healthcare AI automation company that built workflow automation products including prior authorization. Comparable to SamaCare in deploying AI for repetitive administrative healthcare processes, though with a broader workflow scope.

TypeOthers
Description

Telehealth platform (acquired by Amwell) that incorporated prior authorization and care navigation into virtual care workflows. Related to SamaCare as an ecosystem participant integrating PA into broader digital care delivery.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers18 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SamaCare

Medical Benefit Prior Authorization Softwaresamacare.com

SamaCare operates an AI-native medical benefit prior authorization platform serving U.S. specialty practices and pharmaceutical manufacturers, processing $6.2B+ in specialty drug spend annually across 30,000+ providers. The platform is free to providers; revenue comes from pharma clients paying for market access analytics, intervention services, and industry benchmarks.

What SamaCare does

SamaCare operates an AI-native medical benefit prior authorization platform that connects U.S. specialty healthcare providers with pharmaceutical manufacturers through a single unified workflow. Built on a proprietary dataset of over 2 million prior authorizations captured across 30,000+ specialty practices, 97% of U.S. payers, and 8+ years of continuous operation, the platform automates submission, tracking, and denial prevention for high-cost specialty medications administered in retina, oncology, neurology, rheumatology, and infusion settings. Core technology components include a real-time prior authorization data engine, AI-powered point-of-care support, Policy Pre-Check, bulk automated submission, and human-in-the-loop AI processes that learn from frontline specialists. The November 2025 launch of SamaCare Plus extends the platform into touchless, AI-driven prior authorization with provider oversight.

The business model is a two-sided freemium: specialty practices use the core platform free of charge, generating the data asset that underpins SamaCare's value proposition. Revenue is generated on the life sciences side from pharmaceutical manufacturers who subscribe to premium data analytics (SamaCare Insights, Medical Benefit Prior Authorization Benchmarks), intervention services (PA Boost, Auth Inform), and strategic clinical justification support. Distribution combines direct enterprise sales with channel partnerships through Cencora, McKesson, Neuronet GPO, the American Rheumatology Network, NICA, and an EHR integration with NextGen Healthcare. Customers include 40% of leading pharmaceutical companies, with documented outcomes including up to 84% faster time to resolution, 29% higher approval rates, 24% lower patient churn, and up to 42% reduction in avoidable administrative denials. The company is privately held, venture-backed by Questa Capital, Vive Collective, and South Park Commons, and is led by founder and CEO Syam Palakurthy.

SamaCare firmographics

Firmographics
Name
SamaCare
Legal name
SamaCare Inc.
Website
https://samacare.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
SamaCare operates an AI-native medical benefit prior authorization platform serving U.S. specialty practices and pharmaceutical manufacturers, processing $6.2B+ in specialty drug spend annually across 30,000+ providers. The platform is free to providers; revenue comes from pharma clients paying for market access analytics, intervention services, and industry benchmarks.
Ownership category
akta.pro rank

SamaCare industry classification

Industry
Product category
Medical Benefit Prior Authorization Software
NAICS
Custom Computer Programming Services (541511)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACANAO
DTx/SaMD Deployment, Integration & Reimbursement Enablement
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Medical prior authorization
  • Specialty drug access
  • Healthcare workflow automation
  • Market access analytics
  • AI prior authorization

Where SamaCare is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices2 records

Markets served

SamaCare business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Life Sciences / Pharmaceutical Services: Premium services and data analytics for pharmaceutical brands to improve access to therapy. Revenue generated from pharmaceutical manufacturers who pay for market access insights, intervention support, and data analytics services. Clients include 40% of leading pharmaceutical companies.
  2. Provider Platform (Free Tier): SamaCare's prior authorization platform is free to clinics, ensuring patients get on the right therapy at the right time. This creates network effects and data advantages that benefit the pharmaceutical side of the business.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree prior authorization platform for providers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

SamaCare product offering

Product offering

Core offering

SamaCare operates an AI-native medical benefit prior authorization platform, known as the Script-to-Therapy Operating System, that automates submission, tracking, and denial prevention for specialty medications across all major U.S. payers. The platform is offered free to specialty healthcare providers and monetizes via premium data analytics and intervention services sold to pharmaceutical manufacturers, processing over $6.2B in annual specialty drug spend.

Product overview

SamaCare offers a unified Script-to-Therapy Operating System for medical benefit prior authorization, built on a best-in-class AI tech stack and the largest real-world dataset in medical benefit prior authorization. The core platform provides automated, AI-native prior authorization submission and tracking across all major U.S. payers, available free to specialty practices. The product portfolio includes multiple AI-powered modules: SamaCare Plus (touchless prior authorizations), Policy Pre-Check (policy alignment before submission), AI-Powered Point-of-Care Support (real-time denial avoidance guidance), and SamaCare Insights (data analytics for manufacturers). For life sciences clients, SamaCare offers premium services including PA Boost, Auth Inform, and strategic intervention services, along with the Medical Benefit Prior Authorization Benchmarks for industry-wide visibility. The platform processes over $6B+ in medical benefit drug spend annually across more than 15,000 providers and supports 40% of the U.S. ambulatory infusion center market.

Differentiator

Problem solved

Functional benefit

Brands

  • SamaCare Insights: AI-powered data analytics and insights platform providing real-time prior authorization performance data and benchmarks.
  • AI-Powered Point-of-Care Support
  • Policy Pre-Check
  • SamaCare Plus
  • PA Boost
  • Auth Inform
  • Script-to-Therapy Operating System

Products and services

  • Script-to-Therapy Operating System (Provider Portal)
  • SamaCare Plus
  • SamaCare Insights
  • PA Boost
  • Auth Inform
  • Medical Benefit Prior Authorization Benchmarks
  • Premium Services (Strategic Interventions)

Quantifiable outcome

  • Up to 84% faster Time to Resolution
  • +6 more outcomes

Companies that use SamaCare

Customer profile

Named customers18 records

Segments3 records

Ideal customer profiles3 records

SamaCare technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature8 records

SamaCare partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • American Rheumatology Network (ARN)coreChannel Partner/ Reseller/ Distributor · 25 January 2023National partnership to bring streamlined prior authorization to a network of over 460 community-based rheumatology providers.
  • NextGen HealthcarecoreTechnology or Integration · 10 January 2023Integration partnership enabling seamless data transfer between NextGen EHR and SamaCare's prior authorization platform.
  • National Infusion Center Association (NICA)coreStrategic or Co-development PartnerCo-hosted webinar on unifying prior authorization data for infusion centers; ongoing collaboration on industry standards and education.
  • WeInfuseminorStrategic or Co-development PartnerCo-presented webinar on infusion operations and workflow automation with leading infusion provider FlexCare.
  • Healthcare Business TodayminorGTM or Marketing PartnerContent partnership for article publication on provider-administered drug launches in competitive markets.
  • Immunoglobulin National Society (IgNS)minorStrategic or Co-development PartnerFeatured partner on Road to Care podcast episode about IG therapy standardization; both organizations focused on improving patient access to specialty therapies.

Scale indicators14 records

Recent moves6 records

Expansion highlights5 records

SamaCare competitors and assessment

Company assessment

Direct peers

  • CoverMyMeds: The leading electronic prior authorization (ePA) platform for prescriptions and specialty medications, now part of McKesson's RxTS business. Directly comparable to SamaCare in automating PA workflows between providers, payers, and pharma manufacturers.
  • Surescripts: Operates one of the largest ePA networks in the U.S., connecting providers, payers, and pharmacy benefit managers. Comparable to SamaCare as a network-driven prior authorization and medication intelligence infrastructure player.
  • Cohere Health: AI-driven prior authorization and utilization management platform focused on specialty care and value-based care arrangements. Direct competitor to SamaCare in automating medical and specialty PA with intelligent clinical decisioning.

Emerging players

  • Anterior: AI-native prior authorization company applying large language models to reduce administrative denials. Comparable to SamaCare Plus in targeting touchless PA with deep AI capabilities, though at an earlier stage.
  • Notable Health: Intelligent automation platform using AI to streamline administrative workflows for healthcare providers, including prior authorization. Comparable to SamaCare in targeting PA automation and broader workflow reduction with AI.
  • Olive AI: Healthcare AI automation company that built workflow automation products including prior authorization. Comparable to SamaCare in deploying AI for repetitive administrative healthcare processes, though with a broader workflow scope.

Broad incumbents

  • Waystar: Public healthcare revenue cycle management platform with prior authorization capabilities as part of a broader RCM suite. Overlaps with SamaCare in PA workflows but serves a much wider hospital and ambulatory RCM footprint.
  • Optum (UnitedHealth Group): Largest healthcare technology and services platform in the U.S., including Change Healthcare, which provides PA, claims, and clinical connectivity solutions. Competes with SamaCare through vertically integrated payer-provider data and analytics.
  • Experian Health: Healthcare data, identity, and automation vendor with prior authorization and eligibility solutions. Comparable to SamaCare in automating medical benefit workflows for providers and payers, but as part of a broader credit and data analytics portfolio.

Others

  • Avizia (Amwell): Telehealth platform (acquired by Amwell) that incorporated prior authorization and care navigation into virtual care workflows. Related to SamaCare as an ecosystem participant integrating PA into broader digital care delivery.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

SamaCare social profiles

Digital presence

SamaCare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SamaCare leadership team

Management profile

Number of profiles

Profiles5 records

SamaCare funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SamaCare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SamaCare

What does SamaCare do?

SamaCare operates an AI-native medical benefit prior authorization platform, known as the Script-to-Therapy Operating System, that automates submission, tracking, and denial prevention for specialty medications across all major U.S. payers. The platform is offered free to specialty healthcare providers and monetizes via premium data analytics and intervention services sold to pharmaceutical manufacturers, processing over $6.2B in annual specialty drug spend.

Is SamaCare a public or private company?

SamaCare is a private company. It is classified as venture growth investor backed and is currently operating.

When was SamaCare founded?

SamaCare was founded in 2017. It employs 11 to 50 people.

Where is SamaCare based?

SamaCare is headquartered in San Francisco, United States, in the North America region.

How does SamaCare make money?

Two revenue lines are on record. Life Sciences / Pharmaceutical Services are the primary driver. The others are provider Platform (Free Tier).

Who are SamaCare's main competitors?

Direct peers on record are CoverMyMeds, Surescripts and Cohere Health. Emerging players are Anterior, Notable Health and Olive AI. Broad incumbents are Waystar, Optum (UnitedHealth Group) and Experian Health. Avizia (Amwell) is listed as an others.

Does SamaCare have an API?

No public API is recorded for SamaCare.

What industry is SamaCare in?

SamaCare's product category is Medical Benefit Prior Authorization Software. Its primary akta.pro industry code is HLACANAO, DTx/SaMD Deployment, Integration & Reimbursement Enablement, with a secondary code of HLACANAM, DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms. Its NAICS code is 541511 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AijournSamaCare Named 2026 Prix Galien USA Finalist for Best Digital Health SolutionSamaCare has been named a 2026 Prix Galien USA finalist in the Best Digital Health Solution category for its AI-powered Medical Benefit Prior Authorization Intelligence Platform. The recognition highlights the company's technology designed to streamline administrative processes and reduce delays for patients accessing specialty therapies. This selection places SamaCare among 23 nominees in a year marking the 20th anniversary of the awards.PR NewswireSamaCare Ranks in Top 25% of 2026 Inc. 5000 for Third Consecutive YearSamaCare ranked No. 1021 on the 2026 Inc. 5000 list, placing it in the top 25% of fastest-growing private companies for the third consecutive year. The AI-powered prior authorization platform expanded its insights solution and published the first Market Access Benchmarks for medical benefit prior authorization performance.PR NewswireSamaCare Releases Q2 2026 Market Access Benchmarks for Medical Benefit DrugsSamaCare released its Q2 2026 Market Access Benchmarks for medical benefit drugs, reporting a 76.5% average net prior authorization approval rate and a 2.09-day average time to resolution across its platform without manufacturer-sponsored intervention support. The analysis revealed significant variation by therapy stage (initiation vs. continuation), specialty, medication type, and payer workflow, with the slowest payer-specialty combinations averaging over 8.8 days. The benchmarks, derived from prior authorization activity across thousands of practices nationwide, are intended to help life sciences companies and specialty providers identify access friction points and inform market access strategy.AijournSamaCare Launches First-of-Its-Kind Benchmarks for Medical Benefit Prior Authorization PerformanceSamaCare announced the release of its Medical Benefit Prior Authorization Benchmarks, providing life sciences companies and healthcare providers visibility into approval rates and time to therapy for specialty medications. The dataset, derived from real-world prior authorization activity across tens of thousands of specialty practices, addresses a historically limited transparency gap in how prior authorization processes impact patient access to care. The release comes at a time of increasing industry focus on prior authorization reform and transparency.PR NewswireSamaCare Launches First-of-Its-Kind Benchmarks for Medical Benefit Prior Authorization PerformanceSamaCare, a San Francisco-based platform for medical benefit prior authorization, announced the release of its Medical Benefit Prior Authorization Benchmarks, providing life sciences companies and healthcare providers with visibility into approval rates and time to therapy for specialty medications. The new dataset offers a first-of-its-kind benchmark for measuring prior authorization performance across the industry.AijournSamaCare Named to Fast Company’s 2026 Most Innovative Companies ListSamaCare has been named No. 14 in the Healthcare category on Fast Company's 2026 Most Innovative Companies list, recognizing its work on AI-driven prior authorization solutions. The company's platform combines real-world prior authorization data with AI-powered workflow support to help specialty practices reduce delays and preventable denials. In the past 12 months, SamaCare introduced innovations including SamaCare Insights, AI-Powered Point-of-Care Support, and Policy Pre-Check, achieving measurable results such as up to a 42% reduction in avoidable denials and approximately 80% faster time-to-therapy for patients.PR NewswireSamaCare Named to Fast Company's 2026 Most Innovative Companies ListSamaCare, an AI-powered platform for specialty therapy patient access, has been named No. 14 in the Healthcare category on Fast Company's 2026 Most Innovative Companies list. The recognition spotlights SamaCare's work in transforming prior authorization processes through AI-driven workflow support, data analytics, and policy pre-check capabilities. The company's innovations have produced measurable outcomes including up to 42% reduction in avoidable administrative denials, 24% decrease in therapy abandonment, and approximately 80% faster time-to-therapy for patients.PR NewswireSamaCare Surpasses $6.2 Billion in Medical Benefit Drug Prior Authorizations, Highlighting the Proprietary Data Powering SamaCare Artificial Intelligence PlatformSamaCare announced that more than $6.2 billion in specialty medication prior authorizations were processed through its platform in 2025, establishing itself as the leading prior authorization platform for medical benefit drugs in the United States. The platform now supports 40% of the U.S. ambulatory infusion center market and claims to have improved patient access by 40–90%, powered by artificial intelligence trained on over 2 million prior authorizations. This scale enables pharmaceutical manufacturers to access market insights and direct channels to healthcare providers to improve approval rates.PR NewswireSamaCare Launches SamaCare Plus: AI-Driven Touchless Prior Authorizations Built for Provider ControlSamaCare, a prior authorization platform serving specialty practices, has launched SamaCare Plus, an AI-driven solution that automates the prior authorization process while maintaining provider oversight at every step. The platform, built on insights from nearly 2 million prior authorizations and developed in collaboration with design-partner practices, automates form selection, clinical document preparation, payer submission, and status verification. Early adopters report significant reductions in manual work, faster time-to-decision, and higher first-time approval rates for complex medical benefit drugs.